Hasten Biopharmaceutical Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Hasten Biopharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia (NCT06568471) | Hasten Biopharmaceutical Co., Ltd. | 2024-11-16 |
| A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants (NCT06504043) | Hasten Biopharmaceutical Co., Ltd. | 2024-09-17 |
| Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study (NCT05947448) | Hasten Biopharmaceutical Co., Ltd. | 2024-01-22 |
Track Hasten Biopharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.